📗 Cite This Artifact
pasteur-institute
<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">Pasteur Institute</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Logo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Paris, France</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Private Non-profit Foundation</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.pasteur.fr" target="_blank">https://www.pasteur.fr</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), [Neuroinflammation](/mechanisms/neuroinflammation), [Prion Diseases](/diseases/prion)</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1887</td>
</tr>
</table>
Pasteur Institute
Introduction
The Pasteur Institute, founded in 1887 by Louis Pasteur, stands as one of the world's premier biomedical research institutions. Located in Paris, France, the institute was established to study rabies and has since expanded to encompass a broad spectrum of infectious diseases, immunology, and more recently, neurodegenerative disease research.
Pasteur Institute is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
...<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">Pasteur Institute</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Logo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Paris, France</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Private Non-profit Foundation</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.pasteur.fr" target="_blank">https://www.pasteur.fr</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), [Neuroinflammation](/mechanisms/neuroinflammation), [Prion Diseases](/diseases/prion)</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1887</td>
</tr>
</table>
Pasteur Institute
Introduction
The Pasteur Institute, founded in 1887 by Louis Pasteur, stands as one of the world's premier biomedical research institutions. Located in Paris, France, the institute was established to study rabies and has since expanded to encompass a broad spectrum of infectious diseases, immunology, and more recently, neurodegenerative disease research.
Pasteur Institute is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
The Pasteur Institute is a French private non-profit foundation dedicated to the study of biology, microorganisms, diseases, and vaccines. Founded in 1887 by Louis Pasteur, the institute is one of the world's leading research institutions in microbiology and infectious diseases.<sup>[1]</sup>
While primarily known for infectious disease research, Pasteur Institute has expanded its mission to include neurodegenerative disease research, particularly in the areas of neuroinflammation, protein aggregation, and prion diseases.
Neuroscience Research
Neurodegeneration Unit
Pasteur Institute hosts research units focused on:
- Prion Diseases: Understanding the molecular basis of prion propagation and developing therapeutic strategies
- Neuroinflammation: Role of immune responses in neurodegenerative processes
- Protein Aggregation: Mechanisms of toxic protein accumulation in AD, PD, and related disorders
Cellular Neuroscience
Research in cellular neuroscience includes:
- Synaptic function and dysfunction
- Neuronal death mechanisms
- Glial cell biology
- Neurotrophic factors
- Axonal transport defects
- Mitochondrial dysfunction
Neurodegeneration Mechanisms
The institute investigates fundamental mechanisms shared across neurodegenerative diseases:
Protein Misfolding: Understanding how normal proteins misfold and aggregate into toxic species.
Oxidative Stress: Role of reactive oxygen species in neuronal damage.
Energy Metabolism: Mitochondrial dysfunction and cellular energy deficits.
Calcium Dysregulation: Disrupted calcium signaling in neurons and glia.
Research Programs
Prion Research
The Pasteur Institute is a world leader in prion disease research:
- Creutzfeldt-Jakob Disease (CJD): Genetics, pathology, and therapeutic approaches
- Variant CJD: Understanding the link between BSE and human disease
- Animal Prion Diseases: Scrapie, BSE, and chronic wasting disease
Neuroimmunology
Research on neuroimmune interactions:
- [Microglia](/entities/microglia) activation states
- Cytokine signaling in neurodegeneration
- [Blood-brain barrier](/entities/blood-brain-barrier) dysfunction
- Therapeutic targeting of neuroinflammation
Disease Focus
| Disease | Research Focus |
|---------|----------------|
| Prion Diseases | Prion propagation, strain diversity, therapy |
| Alzheimer's Disease | Amyloid, [tau](/proteins/tau), neuroinflammation |
| Parkinson's Disease | [Alpha-synuclein](/proteins/alpha-synuclein), neuroinflammation |
| Multiple Sclerosis | Autoimmunity, demyelination |
Recent Discoveries
Prion Strain Diversity
Pasteur Institute researchers have characterized distinct prion strains and their mechanisms of propagation, leading to improved diagnostic methods and therapeutic strategies[@aguzzi2023]. The work of Simoneau et al. (2023) on prion strain typing using cell-free conversion assays has advanced the field's understanding of strain diversity[@simoneau2023].
Neuroinflammation Pathways
Discovery of novel neuroinflammatory pathways that contribute to neurodegeneration, identifying potential therapeutic targets for Alzheimer's and Parkinson's diseases[@heneka2025][@weeks2023]. Bauer et al. (2022) reviewed the comprehensive role of neuroinflammation in neurodegenerative diseases, establishing mechanistic frameworks for understanding these processes[@bauer2022].
Microglia Research
Pioneering work on [microglia](/cell-types/microglia-neuroinflammation) activation and their dual role in both protecting and damaging the brain in neurodegenerative conditions. Caillaud et al. (2022) demonstrated that microglia have a dual role in prion disease—both protecting the brain and contributing to pathology[@caillaud2022]. Combrisson et al. (2023) applied single-cell analysis to characterize microglia heterogeneity in neurodegenerative diseases[@combrisson2023].
Prion Research Program
The Prion Research Unit at Pasteur Institute represents one of the world's leading programs in prion disease research. Since the emergence of bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD) in the 1990s, Pasteur Institute has been at the forefront of understanding these fatal neurodegenerative disorders.
Creutzfeldt-Jakob Disease (CJD)
Research on sporadic, familial, and iatrogenic CJD encompasses:
Epidemiology: Brandel et al. (2022) provided an updated epidemiological analysis of CJD in France, documenting incidence patterns and risk factors[@brandel2022]. Peyraud et al. (2022) reviewed the clinical and epidemiological features of human prion diseases globally[@peyraud2022].
Pathogenesis: Studies on the cellular and molecular mechanisms of prion propagation, including work by Aguzzi et al. (2023) on mechanisms and therapeutic targets[@aguzzi2023].
Diagnostics: Development of improved diagnostic tools including CSF biomarkers and brain imaging markers.
Variant CJD
Research on vCJD, the human disease linked to BSE exposure, has included:
- Understanding the species barrier and transmission mechanisms
- Characterization of the prion distribution in affected brains[@haik2004]
- Development of blood-based diagnostic tests
- Studies on the potential for secondary transmission
Animal Prion Diseases
The institute investigates naturally occurring and experimental animal prion diseases including:
- Scrapie in sheep and goats
- Bovine spongiform encephalopathy (BSE)
- Chronic wasting disease (CWD) in cervids
- Transmissible mink encephalopathy
Therapeutic Development
Research on prion disease therapeutics includes:
- Antisense oligonucleotide approaches
- Small molecule inhibitors of prion propagation
- Antibody-based therapies
- Gene editing strategies
Vignal et al. (2023) reviewed molecular mechanisms of neurodegeneration in prion diseases, providing targets for therapeutic intervention[@vignal2023].
Neuroinflammation Research
Microglia Biology
Pasteur Institute researchers have made fundamental contributions to understanding microglia in neurodegenerative diseases:
Activation States: Studies defining the spectrum of microglia activation states, from pro-inflammatory (M1) to neuroprotective (M2) phenotypes.
Dual Role: Recognition that microglia can both protect neurons and contribute to pathology depending on context and activation state[@caillaud2022].
Therapeutic Targeting: Development of strategies to modulate microglia toward neuroprotective phenotypes.
Cytokine and Chemokine Signaling
Research on inflammatory mediators in neurodegeneration:
- Interleukin-1 beta (IL-1β) and its role in neuronal dysfunction
- Tumor necrosis factor-alpha (TNF-α) in neurotoxicity
- Chemokine signaling in glial recruitment
- Anti-inflammatory cytokines as potential therapeutics
Blood-Brain Barrier
Studies on BBB dysfunction in neurodegenerative conditions:
- Mechanisms of BBB breakdown in AD and PD
- Peripheral immune cell infiltration into the CNS
- Therapeutic strategies to restore BBB integrity
- Drug delivery across the BBB
Depression and Neuroinflammation
Belzung et al. (2023) explored the relationship between neuroinflammation and depression, a common non-motor symptom in Parkinson's disease and other neurodegenerative conditions[@belzung2023].
Alzheimer's Disease Research
Amyloid and Tau Pathology
Research on the core pathological features of AD:
Chasseigneaux et al. (2023) investigated amyloid-beta and tau pathology in early-onset Alzheimer's disease, identifying differences from late-onset forms[@chasseigneaux2023].
Amyloid Hypothesis: Studies on amyloid-beta generation, aggregation, and toxicity.
Tau Pathology: Research on tau phosphorylation, aggregation, and propagation.
Interaction: Understanding how amyloid and tau pathologies interact.
Neuroinflammation in AD
The institute has made significant contributions to understanding neuroinflammation in AD:
- Microglia activation and amyloid clearance
- Astrocyte contributions to neuroinflammation
- Complement system involvement
- Therapeutic targeting of neuroinflammation[@weeks2023]
Biomarker Development
Jaouen et al. (2024) reviewed blood biomarkers for neurodegenerative diseases, including current status and future directions[@jaouen2024].
Parkinson's Disease Research
Alpha-Synuclein Research
Studies on the protein central to PD pathogenesis:
Lazaro et al. (2023) used animal models to investigate alpha-synuclein aggregation in Parkinson's disease, providing new insights into disease mechanisms[@lazaro2023].
Research areas include:
- Alpha-synuclein structure and aggregation
- Propagation of pathology between neurons
- Cell-to-cell transmission
- Strain diversity in synucleinopathies
Neuroinflammation in PD
Investigation of inflammatory processes in PD:
- Microglial activation in PD brains
- Peripheral immune system involvement
- Inflammatory biomarkers
- Anti-inflammatory therapeutic strategies
Parkinson's Plus Syndromes
Research on atypical parkinsonian disorders:
- Multiple System Atrophy (MSA)
- Progressive Supranuclear Palsy (PSP)
- Corticobasal Degeneration (CBD)
- Dementia with Lewy Bodies (DLB)
Structural Biology and Drug Discovery
Protein Structure Analysis
Pasteur Institute researchers use advanced techniques to understand protein structure:
Cryo-Electron Microscopy: Determining the structure of amyloid fibrils and prion proteins at near-atomic resolution.
X-ray Crystallography: Solving the structure of protein domains involved in aggregation.
NMR Spectroscopy: Studying protein dynamics and interactions in solution.
High-Throughput Screening
The institute maintains screening facilities for drug discovery:
- Compound library screening
- Target identification
- Hit validation
- Lead optimization
Computational Approaches
- Molecular docking simulations
- Machine learning for compound design
- Protein folding predictions
- Virtual screening
Clinical Research and Patient Care
Clinical Trials
Pasteur Institute participates in clinical trials for:
- Prion disease therapeutics
- Alzheimer's disease treatments
- Parkinson's disease therapies
- Neuroinflammation modulators
Diagnostic Development
- Cerebrospinal fluid biomarkers
- Blood-based diagnostics
- Neuroimaging markers
- Genetic testing services
Patient Registries
- Prion disease registry
- Alzheimer's disease cohort
- Parkinson's disease cohort
- Rare neurodegenerative disease registry
Training Programs
Rodriguez et al. (2024) reviewed CRISPR-based therapies for neurodegenerative diseases, presenting current approaches and future directions[@rodriguez2024].
Training Programs
International PhD Program
Pasteur Institute offers a prestigious international PhD program in microbiology and neuroscience:
- Multi-disciplinary training
- Access to state-of-the-art facilities
- International student body
- English-taught courses
Postdoctoral Training
Research fellowships in specialized units:
- Prion Biology Unit
- Neuroinflammation Unit
- Cellular Neuroscience Unit
- Stem Cell and Regeneration Unit
Summer Courses
Intensive courses in microbiology and immunology open to international students:
- Prion Diseases Workshop
- Neuroimmunology Course
- Advanced Microscopy Techniques
International Network
Global Presence
The Pasteur Institute network comprises 32 institutes worldwide:
- Europe: France (headquarters), Belgium, Italy, Spain, Greece, Portugal, Poland, Hungary, Romania, Bulgaria, Serbia, Russia
- Asia: Vietnam, Cambodia, Laos, Myanmar, Indonesia, China, Iran, Afghanistan, Pakistan
- Africa: Morocco, Algeria, Tunisia, Senegal, Côte d'Ivoire, Burkina Faso, Niger, Madagascar, Cameroon, Central African Republic, Congo
- Americas: Canada, French West Indies, French Guiana
Collaborative Research
The international network enables:
- Global surveillance of infectious diseases
- Shared research resources and protocols
- Training exchanges
- Joint research projects
- Harmonized biosafety standards
- Common data repositories
European Partnerships
Horizon Europe projects and other EU-funded research initiatives:
- Neurodegenerative disease research networks
- Prion disease surveillance
- Antimicrobial resistance
- Human Brain Project collaborations
- Innovative Medicines Initiative
NIH Collaborations
Partnerships with US National Institutes of Health:
- Joint research projects
- Training exchanges
- Data sharing
- Clinical trial collaborations
- Prion surveillance networks
Industry Partnerships
Strategic collaborations with pharmaceutical and biotechnology companies:
- Drug development programs
- Clinical trial execution
- Diagnostic test validation
- Biomarker discovery
Historical Context and Scientific Legacy
Foundation and Early Years
The Pasteur Institute was founded in 1887 following Louis Pasteur's successful development of a rabies vaccine. The original mission was to study infectious diseases and develop vaccines, but the institute's scope has expanded dramatically over more than a century.
Nobel Prize Legacy
Pasteur Institute researchers have contributed to multiple Nobel Prizes:
- 1907: Alphonse Laveran (Physiology or Medicine)
- 1908: Élie Metchnikoff (Physiology or Medicine)
- 1928: Charles Nicolle (Physiology or Medicine)
- 1965: François Jacob (Physiology or Medicine)
- 2008: Françoise Barré-Sinoussi (Physiology or Medicine)
Evolution to Neurodegeneration Research
While infectious disease research remains central to the institute's mission, the recognition that neuroinflammation plays a key role in many neurodegenerative diseases has led to expansion into this field. The expertise in immunology, protein biology, and disease mechanisms translates naturally to studying Alzheimer's, Parkinson's, and prion diseases.
Research Infrastructure
Core Facilities
The institute provides state-of-the-art core facilities:
Genomics Platform: Next-generation sequencing, single-cell genomics, epigenomics
Proteomics Platform: Mass spectrometry, protein sequencing, interactomics
Imaging Platform: Confocal microscopy, electron microscopy, super-resolution, live-cell imaging
Animal Facility: Specific pathogen-free (SPF) animal colonies, genetically engineered models
Clinical Research Unit: Phase I-II clinical trial capabilities
Biobanking
The institute maintains repositories of:
- Human brain tissue samples
- CSF and blood samples
- DNA and RNA collections
- Animal tissue banks
- Cell lines
Data Science
Computational infrastructure for:
- Big data analysis
- Machine learning and AI
- Systems biology modeling
- Bioinformatics pipelines
Future Directions
Emerging Research Areas
Single-Cell Analysis: Understanding cellular heterogeneity in neurodegeneration through single-cell genomics and proteomics[@combrisson2023].
Gene Editing: CRISPR approaches for neurological disorders, including both therapeutic development and disease modeling[@rodriguez2024].
Stem Cell Models: iPSC-derived neurons and glia for disease modeling and drug screening[@marschall2023].
Therapeutic Development: Novel compounds for neurodegenerative diseases, including prion disease therapeutics and immunomodulatory approaches.
Strategic Priorities
Funding and Investment
The institute receives funding from multiple sources:
- French government (ANR, INSERM, CNRS)
- European Union (Horizon Europe)
- NIH and international agencies
- Private foundations
- Industry partnerships
Significant investment in neurodegenerative disease research has enabled expansion of facilities, recruitment of new investigators, and development of new programs.
Impact and Contributions
Scientific Output
Pasteur Institute researchers publish extensively in leading journals:
- Nature, Science, Cell
- Nature Neuroscience, Neuron
- Brain, Acta Neuropathologica
- Lancet Neurology, Nature Reviews Neurology
Training Output
The institute has trained numerous leaders in neuroscience:
- Principal investigators worldwide
- Industry research leaders
- Clinical researchers
- Public health officials
Public Health Impact
Contributions to public health include:
- Surveillance networks for prion diseases
- Diagnostic standards and protocols
- Public education materials
- Policy advisory roles
See Also
- [French National Research Organizations](/institutions)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Prion Disease](/diseases/prion-disease)
- [Neuroinflammation](/mechanisms/neuroinflammation)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Microglia](/cell-types/microglia-neuroinflammation)
External Links
- [Pasteur Institute](https://www.pasteur.fr)
- [Pasteur Institute Research](https://www.pasteur.fr/en/research)
- [International Network](https://www.pasteur.fr/en/international)
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | institutions-pasteur-institute |
| kg_node_id | None |
| entity_type | institution |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-3e23d2e19c10 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'institutions-pasteur-institute'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-institutions-pasteur-institute?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[pasteur-institute](http://scidex.ai/artifact/wiki-institutions-pasteur-institute)
http://scidex.ai/artifact/wiki-institutions-pasteur-institute